Are survival outcomes dependent on the tumor dose threshold of 139 Gy in patients with chemorefractory metastatic colorectal cancer treated with yttrium-90 radioembolization using glass particles? A real-world single-Centre study.
Osman Melih TopçuoğluTolga OrhanAyşegul GormezNalan AlanPublished in: The British journal of radiology (2024)
This study demonstrated that increased tumour absorbed doses in radioembolization may not provide additional significant advantage for OS and hPFS for patients with CRCLM.